1
|
The Interconnected Mechanisms of Oxidative Stress and Neuroinflammation in Epilepsy. Antioxidants (Basel) 2022; 11:antiox11010157. [PMID: 35052661 PMCID: PMC8772850 DOI: 10.3390/antiox11010157] [Citation(s) in RCA: 35] [Impact Index Per Article: 17.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Revised: 01/05/2022] [Accepted: 01/10/2022] [Indexed: 12/16/2022] Open
Abstract
One of the most important characteristics of the brain compared to other organs is its elevated metabolic demand. Consequently, neurons consume high quantities of oxygen, generating significant amounts of reactive oxygen species (ROS) as a by-product. These potentially toxic molecules cause oxidative stress (OS) and are associated with many disorders of the nervous system, where pathological processes such as aberrant protein oxidation can ultimately lead to cellular dysfunction and death. Epilepsy, characterized by a long-term predisposition to epileptic seizures, is one of the most common of the neurological disorders associated with OS. Evidence shows that increased neuronal excitability—the hallmark of epilepsy—is accompanied by neuroinflammation and an excessive production of ROS; together, these factors are likely key features of seizure initiation and propagation. This review discusses the role of OS in epilepsy, its connection to neuroinflammation and the impact on synaptic function. Considering that the pharmacological treatment options for epilepsy are limited by the heterogeneity of these disorders, we also introduce the latest advances in anti-epileptic drugs (AEDs) and how they interact with OS. We conclude that OS is intertwined with numerous physiological and molecular mechanisms in epilepsy, although a causal relationship is yet to be established.
Collapse
|
2
|
The Role of Cardiac N-Methyl-D-Aspartate Receptors in Heart Conditioning-Effects on Heart Function and Oxidative Stress. Biomolecules 2020; 10:biom10071065. [PMID: 32708792 PMCID: PMC7408261 DOI: 10.3390/biom10071065] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Revised: 07/07/2020] [Accepted: 07/09/2020] [Indexed: 12/17/2022] Open
Abstract
As well as the most known role of N-methyl-D-aspartate receptors (NMDARs) in the nervous system, there is a plethora of evidence that NMDARs are also present in the cardiovascular system where they participate in various physiological processes, as well as pathological conditions. The aim of this study was to assess the effects of preconditioning and postconditioning of isolated rat heart with NMDAR agonists and antagonists on heart function and release of oxidative stress biomarkers. The hearts of male Wistar albino rats were subjected to global ischemia for 20 min, followed by 30 min of reperfusion, using the Langendorff technique, and cardiodynamic parameters were determined during the subsequent preconditioning with the NMDAR agonists glutamate (100 µmol/L) and (RS)-(Tetrazol-5-yl)glycine (5 μmol/L) and the NMDAR antagonists memantine (100 μmol/L) and MK-801 (30 μmol/L). In the postconditioning group, the hearts were perfused with the same dose of drugs during the first 3 min of reperfusion. The oxidative stress biomarkers were determined spectrophotometrically in samples of coronary venous effluent. The NMDAR antagonists, especially MK-801, applied in postconditioning had a marked antioxidative effect with a most pronounced protective effect. The results from this study suggest that NMDARs could be a potential therapeutic target in the prevention and treatment of ischemic and reperfusion injury of the heart.
Collapse
|
3
|
Das A, Fröhlich D, Achanta LB, Rowlands BD, Housley GD, Klugmann M, Rae CD. L-Aspartate, L-Ornithine and L-Ornithine-L-Aspartate (LOLA) and Their Impact on Brain Energy Metabolism. Neurochem Res 2020; 45:1438-1450. [PMID: 32424601 DOI: 10.1007/s11064-020-03044-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2020] [Revised: 04/25/2020] [Accepted: 04/29/2020] [Indexed: 12/11/2022]
Abstract
L-Ornithine-L-aspartate (LOLA), a crystalline salt, is used primarily in the management of hepatic encephalopathy. The degree to which it might penetrate the brain, and the effects it might have on metabolism in brain are poorly understood. Here, to investigate the effects of LOLA on brain energy metabolism we incubated brain cortical tissue slices from guinea pig (Cavea porcellus) with the constituent amino acids of LOLA, L-ornithine or L-aspartate, as well as LOLA, in the presence of [1-13C]D-glucose and [1,2-13C]acetate; these labelled substrates are useful indicators of brain metabolic activity. L-Ornithine produced significant "sedative" effects on brain slice metabolism, most likely via conversion of ornithine to GABA via the ornithine aminotransferase pathway, while L-aspartate showed concentration-dependent excitatory effects. The metabolic effects of LOLA reflected a mix of these two different processes and were concentration-dependent. We also investigated the effect of an intraperitoneal bolus injection of L-ornithine, L-aspartate or LOLA on levels of metabolites in kidney, liver and brain cortex and brain stem in mice (C57Bl6J) 1 h later. No significant changes in metabolite levels were seen following the bolus injection of L-aspartate, most likely due to rapid metabolism of aspartate before reaching the target tissue. Brain cortex glutamate was decreased by L-ornithine but no other brain effects were observed with any other compound. Kidney levels of aspartate were increased after injection of L-ornithine and LOLA which may be due to interference by ornithine with the kidney urea cycle. It is likely that without optimising chronic intravenous infusion, LOLA has minimal impact on healthy brain energy metabolism due to systemic clearance and the blood - brain barrier.
Collapse
Affiliation(s)
- Abhijit Das
- Neuroscience Research Australia, Barker St, Randwick, NSW, 2031, Australia.,School of Medical Sciences, The University of New South Wales, Sydney, NSW, Australia
| | - Dominik Fröhlich
- Translational Neuroscience Facility, School of Medical Sciences, The University of New South Wales, Kensington, 2052, Australia
| | - Lavanya B Achanta
- Neuroscience Research Australia, Barker St, Randwick, NSW, 2031, Australia.,Translational Neuroscience Facility, School of Medical Sciences, The University of New South Wales, Kensington, 2052, Australia
| | - Benjamin D Rowlands
- Neuroscience Research Australia, Barker St, Randwick, NSW, 2031, Australia.,Translational Neuroscience Facility, School of Medical Sciences, The University of New South Wales, Kensington, 2052, Australia
| | - Gary D Housley
- Translational Neuroscience Facility, School of Medical Sciences, The University of New South Wales, Kensington, 2052, Australia
| | - Matthias Klugmann
- Translational Neuroscience Facility, School of Medical Sciences, The University of New South Wales, Kensington, 2052, Australia
| | - Caroline D Rae
- Neuroscience Research Australia, Barker St, Randwick, NSW, 2031, Australia. .,School of Medical Sciences, The University of New South Wales, Sydney, NSW, Australia.
| |
Collapse
|
4
|
Abstract
Metabolomics analysis provides a unique opportunity for comprehensive mapping of glutamatergic system function using high-throughput metabolite analysis and providing a perspective of the enzymatic activity, which cannot be obtained by other systems biology techniques.
Collapse
|
5
|
McNair LF, Kornfelt R, Walls AB, Andersen JV, Aldana BI, Nissen JD, Schousboe A, Waagepetersen HS. Metabolic Characterization of Acutely Isolated Hippocampal and Cerebral Cortical Slices Using [U-13C]Glucose and [1,2-13C]Acetate as Substrates. Neurochem Res 2016; 42:810-826. [DOI: 10.1007/s11064-016-2116-5] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2016] [Revised: 11/11/2016] [Accepted: 11/16/2016] [Indexed: 12/21/2022]
|
6
|
Furlong TM, Duncan JR, Corbit LH, Rae CD, Rowlands BD, Maher AD, Nasrallah FA, Milligan CJ, Petrou S, Lawrence AJ, Balleine BW. Toluene inhalation in adolescent rats reduces flexible behaviour in adulthood and alters glutamatergic and GABAergic signalling. J Neurochem 2016; 139:806-822. [PMID: 27696399 DOI: 10.1111/jnc.13858] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2016] [Revised: 09/15/2016] [Accepted: 09/18/2016] [Indexed: 12/24/2022]
Abstract
Toluene is a commonly abused inhalant that is easily accessible to adolescents. Despite the increasing incidence of use, our understanding of its long-term impact remains limited. Here, we used a range of techniques to examine the acute and chronic effects of toluene exposure on glutameteric and GABAergic function, and on indices of psychological function in adult rats after adolescent exposure. Metabolomics conducted on cortical tissue established that acute exposure to toluene produces alterations in cellular metabolism indicative of a glutamatergic and GABAergic profile. Similarly, in vitro electrophysiology in Xenopus oocytes found that acute toluene exposure reduced NMDA receptor signalling. Finally, in an adolescent rodent model of chronic intermittent exposure to toluene (10 000 ppm), we found that, while toluene exposure did not affect initial learning, it induced a deficit in updating that learning when response-outcome relationships were reversed or degraded in an instrumental conditioning paradigm. There were also group differences when more effort was required to obtain the reward; toluene-exposed animals were less sensitive to progressive ratio schedules and to delayed discounting. These behavioural deficits were accompanied by changes in subunit expression of both NMDA and GABA receptors in adulthood, up to 10 weeks after the final exposure to toluene in the hippocampus, prefrontal cortex and ventromedial striatum; regions with recognized roles in behavioural flexibility and decision-making. Collectively, our data suggest that exposure to toluene is sufficient to induce adaptive changes in glutamatergic and GABAergic systems and in adaptive behaviour that may underlie the deficits observed following adolescent inhalant abuse, including susceptibility to further drug-use.
Collapse
Affiliation(s)
- Teri M Furlong
- Brain & Mind Centre, University of Sydney, Sydney, New South Wales, Australia.,School of Psychology, University of Sydney, Sydney, New South Wales, Australia
| | - Jhodie R Duncan
- The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.,Department of Anatomy and Neuroscience, University of Melbourne, Melbourne, Victoria, Australia
| | - Laura H Corbit
- School of Psychology, University of Sydney, Sydney, New South Wales, Australia
| | - Caroline D Rae
- Neuroscience Research Australia, Randwick, New South Wales, Australia.,School of Medical Sciences, University of NSW, Kensington, New South Wales, Australia
| | - Benjamin D Rowlands
- Neuroscience Research Australia, Randwick, New South Wales, Australia.,School of Medical Sciences, University of NSW, Kensington, New South Wales, Australia
| | - Anthony D Maher
- Neuroscience Research Australia, Randwick, New South Wales, Australia
| | | | - Carol J Milligan
- The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia
| | - Steven Petrou
- The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia
| | - Andrew J Lawrence
- The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia
| | - Bernard W Balleine
- Brain & Mind Centre, University of Sydney, Sydney, New South Wales, Australia.,School of Psychology, University of NSW, Kensington, New South Wales, Australia
| |
Collapse
|
7
|
Rae C, Nasrallah FA, Balcar VJ, Rowlands BD, Johnston GAR, Hanrahan JR. Metabolomic Approaches to Defining the Role(s) of GABAρ Receptors in the Brain. J Neuroimmune Pharmacol 2015; 10:445-56. [PMID: 25577264 DOI: 10.1007/s11481-014-9579-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2014] [Accepted: 12/26/2014] [Indexed: 10/24/2022]
Abstract
The inhibitory neurotransmitter γ-aminobutyric acid (GABA) acts through various types of receptors in the central nervous system. GABAρ receptors, defined by their characteristic pharmacology and presence of ρ subunits in the channel structure, are poorly understood and their role in the cortex is ill-defined. Here, we used a targeted pharmacological, NMR-based functional metabolomic approach in Guinea pig brain cortical tissue slices to identify a distinct role for these receptors. We compared metabolic fingerprints generated by a range of ligands active at GABAρ and included these in a principal components analysis with a library of other metabolic fingerprints obtained using ligands active at GABAA and GABAB, with inhibitors of GABA uptake and with compounds acting to inhibit enzymes active in the GABAergic system. This enabled us to generate a metabolic "footprint" of the GABAergic system which revealed classes of metabolic activity associated with GABAρ which are distinct from other GABA receptors. Antagonised GABAρ produce large metabolic effects at extrasynaptic sites suggesting they may be involved in tonic inhibition.
Collapse
Affiliation(s)
- Caroline Rae
- Neuroscience Research Australia, Barker St, Randwick, NSW, 2031, Australia,
| | | | | | | | | | | |
Collapse
|
8
|
Hebron M, Chen W, Miessau MJ, Lonskaya I, Moussa CEH. Parkin reverses TDP-43-induced cell death and failure of amino acid homeostasis. J Neurochem 2013; 129:350-61. [PMID: 24298989 DOI: 10.1111/jnc.12630] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2013] [Revised: 11/27/2013] [Accepted: 11/27/2013] [Indexed: 12/13/2022]
Abstract
The E3 ubiquitin ligase Parkin plays a central role in the pathogenesis of many neurodegenerative diseases. Parkin promotes specific ubiquitination and affects the localization of transactivation response DNA-binding protein 43 (TDP-43), which controls the translation of thousands of mRNAs. Here we tested the effects of lentiviral Parkin and TDP-43 expression on amino acid metabolism in the rat motor cortex using high frequency ¹³C NMR spectroscopy. TDP-43 expression increased glutamate levels, decreased the levels of other amino acids, including glutamine, aspartate, leucine and isoleucine, and impaired mitochondrial tricarboxylic acid cycle. TDP-43 induced lactate accumulation and altered the balance between excitatory (glutamate) and inhibitory (GABA) neurotransmitters. Parkin restored amino acid levels, neurotransmitter balance and tricarboxylic acid cycle metabolism, rescuing neurons from TDP-43-induced apoptotic death. Furthermore, TDP-43 expression led to an increase in 4E-BP levels, perhaps altering translational control and deregulating amino acid synthesis; while Parkin reversed the effects of TDP-43 on the 4E-BP signaling pathway. Taken together, these data suggest that Parkin may affect TDP-43 localization and mitigate its effects on 4E-BP signaling and loss of amino acid homeostasis.
Collapse
Affiliation(s)
- Michaeline Hebron
- Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, USA
| | | | | | | | | |
Collapse
|
9
|
Nasrallah FA, Balcar VJ, Rae CD. Activity-dependent γ-aminobutyric acid release controls brain cortical tissue slice metabolism. J Neurosci Res 2011; 89:1935-45. [DOI: 10.1002/jnr.22649] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2010] [Revised: 02/15/2011] [Accepted: 03/01/2011] [Indexed: 12/16/2022]
|
10
|
Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis. Bioanalysis 2011; 1:1615-26. [PMID: 21083107 DOI: 10.4155/bio.09.144] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
Schizophrenia is a severe neuropsychiatric disorder with a poorly understood etiology and progression. We and other research groups have found that energy metabolic pathways in the CNS are perturbed in many subjects with this disorder. Antipsychotic drugs that generally target neurotransmission are currently used for clinical management of the disorder, although these can also have marked effects on energy metabolism in the CNS and periphery. Recent proteomic and metabonomic studies have shown that molecular pathways associated with brain energy metabolism are altered in both the disorder and by antipsychotic treatments. This review focuses on discussion of these molecular alterations. Increased knowledge in this area could facilitate biomarker identification and drug discovery based on improving brain energy metabolism in this debilitating disorder.
Collapse
|
11
|
Nasrallah FA, Maher AD, Hanrahan JR, Balcar VJ, Rae CD. γ-Hydroxybutyrate and the GABAergic footprint: a metabolomic approach to unpicking the actions of GHB. J Neurochem 2010; 115:58-67. [PMID: 20681954 DOI: 10.1111/j.1471-4159.2010.06901.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Gamma-hydroxybutyrate is found both naturally in the brain and self-administered as a drug of abuse. It has been reported to act at endogenous γ-hydroxybutyrate (GHB) receptors and GABA(B) receptors [GABA(B)R], and may also be metabolized to GABA. Here, the metabolic fingerprints of a range of concentrations of GHB were measured in brain cortical tissue slices and compared with those of ligands active at GHB and GABA-R using principal components analysis (PCA) to identify sites of GHB activity. Low concentrations of GHB (1.0 μM) produced fingerprints similar to those of ligands active at GHB receptors and α4-containing GABA(A)R. A total of 10 μM GHB clustered proximate to mainstream GABAergic synapse ligands, such as 1.0 μM baclofen, a GABA(B)R agonist. Higher concentrations of GHB (30 μM) clustered with GABA(C)R agonists and the metabolic responses induced by blockade of the GABA transporter-1 (GAT1). The metabolic responses induced by 60 and 100 μM GHB were mimicked by simultaneous blockade of GAT1 and GAT3, addition of low concentrations of GABA(C)R antagonists, or increasing cytoplasmic GABA concentrations by incubation with the GABA transaminase inhibitor vigabatrin. These data suggest that at concentrations > 30 μM, GHB may be active via metabolism to GABA, which is then acting upon an unidentified GABAergic master switch receptor (possibly a high-affinity extrasynaptic receptor), or GHB may itself be acting directly on an extrasynaptic GABA-R, capable of turning off large numbers of cells. These results offer an explanation for the steep dose-response curve of GHB seen in vivo, and suggest potential target receptors for further investigation.
Collapse
|
12
|
Shin JW, Nguyen KTD, Pow DV, Knight T, Buljan V, Bennett MR, Balcar VJ. Distribution of glutamate transporter GLAST in membranes of cultured astrocytes in the presence of glutamate transport substrates and ATP. Neurochem Res 2009; 34:1758-66. [PMID: 19440835 DOI: 10.1007/s11064-009-9982-z] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2009] [Accepted: 04/20/2009] [Indexed: 11/27/2022]
Abstract
Neurotransmitter L-glutamate released at central synapses is taken up and "recycled" by astrocytes using glutamate transporter molecules such as GLAST and GLT. Glutamate transport is essential for prevention of glutamate neurotoxicity, it is a key regulator of neurotransmitter metabolism and may contribute to mechanisms through which neurons and glia communicate with each other. Using immunocytochemistry and image analysis we have found that extracellular D-aspartate (a typical substrate for glutamate transport) can cause redistribution of GLAST from cytoplasm to the cell membrane. The process appears to involve phosphorylation/dephosphorylation and requires intact cytoskeleton. Glutamate transport ligands L-trans-pyrrolidine-2,4-dicarboxylate and DL-threo-3-benzyloxyaspartate but not anti,endo-3,4-methanopyrrolidine dicarboxylate have produced similar redistribution of GLAST. Several representative ligands for glutamate receptors whether of ionotropic or metabotropic type, were found to have no effect. In addition, extracellular ATP induced formation of GLAST clusters in the cell membranes by a process apparently mediated by P2 receptors. The present data suggest that GLAST can rapidly and specifically respond to changes in the cellular environment thus potentially helping to fine-tune the functions of astrocytes.
Collapse
Affiliation(s)
- Jae-Won Shin
- Anatomy and Histology, School of Medical Sciences and Bosch Institute for Biomedical Research, The University of Sydney, Sydney, NSW 2006, Australia
| | | | | | | | | | | | | |
Collapse
|
13
|
Rae C, Nasrallah FA, Griffin JL, Balcar VJ. Now I know my ABC. A systems neurochemistry and functional metabolomic approach to understanding the GABAergic system. J Neurochem 2009; 109 Suppl 1:109-16. [DOI: 10.1111/j.1471-4159.2009.05803.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Rae C, Nasrallah FA, Bröer S. Metabolic effects of blocking lactate transport in brain cortical tissue slices using an inhibitor specific to MCT1 and MCT2. Neurochem Res 2009; 34:1783-91. [PMID: 19404741 DOI: 10.1007/s11064-009-9973-0] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2009] [Accepted: 04/07/2009] [Indexed: 11/25/2022]
Abstract
A novel inhibitor of lactate transport, AR-C122982, was used to study the effect of inhibiting the monocarboxylate transporters MCT1 and MCT2 on cortical brain slice metabolism. We studied metabolism of L-[3-13C]lactate, and D-[1-13C]glucose under a range of conditions. Experiments using L-[3-13C]lactate showed that the inhibitor AR-C122982 altered exchange of lactate. Under depolarizing conditions, net flux of label from D-[1-13C]glucose was barely altered by 10 or 100 nM AR-C122982. In the presence of AMPA or glutamate there were increases in net flux of label and metabolic pool sizes. These data suggest lactate may supply compartments in the brain not usually directly accessed by glucose. In general, it would appear that movement of lactate between cell types is not essential for metabolic activity, with the heavy metabolic workloads imposed being unaffected by inhibition of MCT1 and MCT2. Further experiments investigating the mechanism of operation of AR-C122982 are necessary to corroborate this finding.
Collapse
Affiliation(s)
- Caroline Rae
- Prince of Wales Medical Research Institute, Barker St., Randwick, NSW 2031, Australia.
| | | | | |
Collapse
|
15
|
Nasrallah FA, Griffin JL, Balcar VJ, Rae C. Understanding your inhibitions: effects of GABA and GABAAreceptor modulation on brain cortical metabolism. J Neurochem 2009; 108:57-71. [DOI: 10.1111/j.1471-4159.2008.05742.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
16
|
Moussa CEH, Rusnak M, Hailu A, Sidhu A, Fricke ST. Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies. Exp Neurol 2008; 209:224-33. [PMID: 18028910 PMCID: PMC3466058 DOI: 10.1016/j.expneurol.2007.09.023] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2007] [Revised: 08/23/2007] [Accepted: 09/19/2007] [Indexed: 12/21/2022]
Abstract
Animal models treated with agricultural chemicals, such as rotenone, reproduce several degenerative features of human central nervous system (CNS) diseases. Glutamate is the most abundant excitatory amino acid transmitter in the mammalian central nervous system and its transmission is implicated in a variety of brain functions including mental behavior and memory. Dysfunction of glutamate neurotransmission in the CNS has been associated with a number of human neurodegenerative diseases, either as a primary or as a secondary factor in the excitotoxic events leading to neuronal death. Since many human CNS disorders do not arise spontaneously in animals, characteristic functional changes have to be mimicked by toxic agents. Candidate environmental toxins bearing any direct or indirect effects on the pathogenesis of human disease are particularly useful. The present longitudinal Magnetic Resonance Imaging (MRI) studies show, for the first time, significant variations in the properties of brain ventricles in a rotenone-treated (2 mg/kg) mouse model over a period of 4 weeks following 3 days of rotenone treatment. Histopathological analysis reveals death of stria terminalis neurons following this short period of rotenone treatment. Furthermore, in vivo voxel localized (1)H MR spectroscopy also shows for the first time significant bio-energetic and metabolic changes as well as temporal alterations in the levels of glutamate in the degenerating striatal region. These studies provide novel insights on the effects of environmental toxins on glutamate and other amino acid neurotransmitters in human neurodegenerative diseases.
Collapse
Affiliation(s)
- Charbel E-H Moussa
- Laboratory of Molecular Neurochemistry, Department of Biochemistry, Molecular and Cell Biology, Georgetown University Medical Center, Washington, DC 20007, USA.
| | | | | | | | | |
Collapse
|
17
|
Nasrallah FA, Griffin JL, Balcar VJ, Rae C. Understanding your inhibitions: modulation of brain cortical metabolism by GABA(B) receptors. J Cereb Blood Flow Metab 2007; 27:1510-20. [PMID: 17293844 DOI: 10.1038/sj.jcbfm.9600453] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Although the impact of neuronal excitation on the functional activity of brain is well understood, the nature of functional responses to inhibitory modulation is far from clear. In this work, we investigated the effects of modulation of the metabotropic GABA(B) receptor on brain metabolism using a targeted neuropharmacological, (1)H/(13)C nuclear magnetic resonance spectroscopy, and metabolomic approach. While agonists at GABA(B) receptors (Baclofen and SKF 97541) generally decreased metabolic activity, mild agonist action could also stimulate metabolism. Less potent antagonists (CGP 35348, Phaclofen) significantly decreased metabolic activity, while more potent antagonists (CGP 52432 and SCH 50911) had opposite, stimulatory, effects. Examination of the data by principal components analysis showed clear divisions of the effects into excitatory and inhibitory components. GABAergic modulation can, therefore, have stimulatory, inhibitory, or even neutral net effects on metabolic activity in brain tissue. This is consistent with GABAergic activity being context dependent, and this conclusion should be taken into account when evaluating functional imaging data involving modulation of neuronal inhibition.
Collapse
Affiliation(s)
- Fatima A Nasrallah
- Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia
| | | | | | | |
Collapse
|
18
|
Bröer S, Bröer A, Hansen JT, Bubb WA, Balcar VJ, Nasrallah FA, Garner B, Rae C. Alanine metabolism, transport, and cycling in the brain. J Neurochem 2007; 102:1758-1770. [PMID: 17504263 DOI: 10.1111/j.1471-4159.2007.04654.x] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Brain glutamate/glutamine cycling is incomplete without return of ammonia to glial cells. Previous studies suggest that alanine is an important carrier for ammonia transfer. In this study, we investigated alanine transport and metabolism in Guinea pig brain cortical tissue slices and prisms, in primary cultures of neurons and astrocytes, and in synaptosomes. Alanine uptake into astrocytes was largely mediated by system L isoform LAT2, whereas alanine uptake into neurons was mediated by Na(+)-dependent transporters with properties similar to system B(0) isoform B(0)AT2. To investigate the role of alanine transport in metabolism, its uptake was inhibited in cortical tissue slices under depolarizing conditions using the system L transport inhibitors 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid and cycloleucine (1-aminocyclopentanecarboxylic acid; cLeu). The results indicated that alanine cycling occurs subsequent to glutamate/glutamine cycling and that a significant proportion of cycling occurs via amino acid transport system L. Our results show that system L isoform LAT2 is critical for alanine uptake into astrocytes. However, alanine does not provide any significant carbon for energy or neurotransmitter metabolism under the conditions studied.
Collapse
Affiliation(s)
- Stefan Bröer
- School of Biochemistry and Molecular Biology, Australian National University, Acton, Canberra ACT, AustraliaSchool of Molecular and Microbial Biosciences, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Anatomy and Histology, The University of Sydney, Sydney, New South Wales, AustraliaPrince of Wales Medical Research Institute, Randwick, New South Wales, AustraliaSchool of Chemistry, The University of New South Wales, Sydney, New South Wales, Australia
| | - Angelika Bröer
- School of Biochemistry and Molecular Biology, Australian National University, Acton, Canberra ACT, AustraliaSchool of Molecular and Microbial Biosciences, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Anatomy and Histology, The University of Sydney, Sydney, New South Wales, AustraliaPrince of Wales Medical Research Institute, Randwick, New South Wales, AustraliaSchool of Chemistry, The University of New South Wales, Sydney, New South Wales, Australia
| | - Jonas T Hansen
- School of Biochemistry and Molecular Biology, Australian National University, Acton, Canberra ACT, AustraliaSchool of Molecular and Microbial Biosciences, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Anatomy and Histology, The University of Sydney, Sydney, New South Wales, AustraliaPrince of Wales Medical Research Institute, Randwick, New South Wales, AustraliaSchool of Chemistry, The University of New South Wales, Sydney, New South Wales, Australia
| | - William A Bubb
- School of Biochemistry and Molecular Biology, Australian National University, Acton, Canberra ACT, AustraliaSchool of Molecular and Microbial Biosciences, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Anatomy and Histology, The University of Sydney, Sydney, New South Wales, AustraliaPrince of Wales Medical Research Institute, Randwick, New South Wales, AustraliaSchool of Chemistry, The University of New South Wales, Sydney, New South Wales, Australia
| | - Vladimir J Balcar
- School of Biochemistry and Molecular Biology, Australian National University, Acton, Canberra ACT, AustraliaSchool of Molecular and Microbial Biosciences, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Anatomy and Histology, The University of Sydney, Sydney, New South Wales, AustraliaPrince of Wales Medical Research Institute, Randwick, New South Wales, AustraliaSchool of Chemistry, The University of New South Wales, Sydney, New South Wales, Australia
| | - Fatima A Nasrallah
- School of Biochemistry and Molecular Biology, Australian National University, Acton, Canberra ACT, AustraliaSchool of Molecular and Microbial Biosciences, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Anatomy and Histology, The University of Sydney, Sydney, New South Wales, AustraliaPrince of Wales Medical Research Institute, Randwick, New South Wales, AustraliaSchool of Chemistry, The University of New South Wales, Sydney, New South Wales, Australia
| | - Brett Garner
- School of Biochemistry and Molecular Biology, Australian National University, Acton, Canberra ACT, AustraliaSchool of Molecular and Microbial Biosciences, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Anatomy and Histology, The University of Sydney, Sydney, New South Wales, AustraliaPrince of Wales Medical Research Institute, Randwick, New South Wales, AustraliaSchool of Chemistry, The University of New South Wales, Sydney, New South Wales, Australia
| | - Caroline Rae
- School of Biochemistry and Molecular Biology, Australian National University, Acton, Canberra ACT, AustraliaSchool of Molecular and Microbial Biosciences, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Anatomy and Histology, The University of Sydney, Sydney, New South Wales, AustraliaPrince of Wales Medical Research Institute, Randwick, New South Wales, AustraliaSchool of Chemistry, The University of New South Wales, Sydney, New South Wales, Australia
| |
Collapse
|
19
|
Moussa CEH, Rae C, Bubb WA, Griffin JL, Deters NA, Balcar VJ. Inhibitors of glutamate transport modulate distinct patterns in brain metabolism. J Neurosci Res 2007; 85:342-50. [PMID: 17086545 DOI: 10.1002/jnr.21108] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
High affinity uptake of glutamate plays a major role in the termination of excitatory neurotransmission. Identification of the ramifications of transporter function is essential to understand the diseases in which defective excitatory amino acid transporters (EAAT) have been implicated. In this work we incubated Guinea pig cortical tissue slices with [3-(13)C]pyruvate and major currently available glutamate uptake inhibitors and studied the resultant metabolic sequelae by (13)C and (1)H NMR spectroscopy using a multivariate statistical approach. Perturbation of glutamate uptake produced significant effects on metabolic flux through the Krebs cycle, and on glutamate/glutamine cycling rates, with this effect accounting for 76% of the variation in the total data set. The effects of all inhibitors were separable from each other along three major principal components. The competitive inhibitor L-CCG III ((2S,1'S,2'R)-2-carboxycyclopropyl)glycine) differed most from the other inhibitors, showing negative weightings on both the first and second principal components, whereas the EAAT2-specific inhibitor dihydrokainate (DHK) showed metabolic patterns similar to that of anti-endo-3,4-methanopyrolidine dicarboxylate but separate from those of DL-threo-beta-benzyloxyaspartate (TBOA) and L-trans-pyrrolidine-2,4-dicarboxylate (L-tPDC). This indicates that different inhibition mechanisms or different colocalisation of the separate transporter subtypes with glutamate receptors can produce significantly different metabolic and functional outcomes for the brain.
Collapse
Affiliation(s)
- Charbel E-H Moussa
- Anatomy and Histology, Institute for Biomedical Research, School of Medical Science, Sydney, Australia
| | | | | | | | | | | |
Collapse
|
20
|
Nasrallah FA, Garner B, Ball GE, Rae C. Modulation of brain metabolism by very low concentrations of the commonly used drug delivery vehicle dimethyl sulfoxide (DMSO). J Neurosci Res 2007; 86:208-14. [PMID: 17853437 DOI: 10.1002/jnr.21477] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Dimethyl sulfoxide (DMSO) has long been used in studies as a vehicle to enhance the solubility and transport of ligands in biological systems. The effects of this drug on the outcomes of such studies are still unclear, with concentrations of DMSO reported as "safe" varying considerably. In the present work, we investigated the effects of very low concentrations of DMSO on the brain metabolism of [3-(13)C]pyruvate and D-[1-(13)C]glucose using (1)H/(13)C NMR spectroscopy and a guinea pig cortical brain slice model. Our results show that DMSO is accumulated by brain slices. DMSO at all concentrations [0.000025%-0.25% (v/v)] increased the metabolic rate when [3-(13)C]pyruvate was used as a substrate and also in the presence of D-[1-(13)C]glucose (0.00025%-0.1% DMSO). These results are consistent with DMSO stimulating respiration, which it may do through altering the kinetics of ATP-requiring reactions. Our results also emphasize that there is no practical concentration of DMSO that can be used in metabolic experiments without effect. Therefore, care should be taken when evaluating the actions of drugs administered in combination with DMSO.
Collapse
|